NCT04823910View on ClinicalTrials.gov

Personalizing Docetaxel Dosing in Advanced Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
Prostate Cancer
Trial Locations (1)

PO6 3LY

Portsmouth Hospitals University NHS Trust, Portsmouth

Sponsors

Lead Sponsor

Physiomics
All Listed Sponsors
collaborator

Portsmouth Hospitals NHS Trust

OTHER_GOV

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Physiomics

INDUSTRY

NCT04823910 - Personalizing Docetaxel Dosing in Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter